IMC:ASX
Immuron Ltd
A$0.040
arrow_upward
+8.11%(+0.0030) 1D
Sep 4, 4:00:00 PM GMT+10 · AUD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IMC...
Open
A$0.04
High
A$0.04
Low
A$0.04
Mkt. cap
11.95M
Avg. vol.
40.09K
Volume
935.15K
52-wk high
A$0.10
52-wk low
A$0.03
EPS
-A$0.02
Shares outstanding
322.85M
No. of employees
7
Open
A$0.04
High
A$0.04
Low
A$0.04
Mkt. cap
11.95M
Avg. vol.
40.09K
Volume
935.15K
52-wk high
A$0.10
52-wk low
A$0.03
EPS
-A$0.02
Shares outstanding
322.85M
No. of employees
7
News stories
From web sources and news partners
TechStock²
·
21 hours ago
Immuron Stock’s 62% Rally Runs Ahead of the PROIBS Numbers
BigGo Finance
·
1 day ago
Immuron Shares Jump 60% on Exclusive U.S. Deal for Gut-Health Product Proibs
Moomoo
·
1 day ago
Trending Stocks Today | Immuron Surges 51.45%
Profile
Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited.
Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment.
In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market. Wikipedia
About Immuron Ltd
CEO-
Employees7
Founded1994
HeadquartersBlackburn North, Victoria, Australia
SectorBiotechnology
Websiteimmuron.com.au